CoreCap Advisors’s Zivo Bioscience, Inc. Common Stock ZIVO Stock Holding History

CoreCap Advisors’s Portfolio ZIVO Stock Details ZIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.6K	Hold	4,360	–	–	﹤0.01%	1853
2026 Q1	$29.4K	Hold	4,360	–	–	﹤0.01%	1518
2025 Q4	$37.9K	Hold	4,360	–	–	﹤0.01%	1432
2025 Q3	$56.7K	Hold	4,360	–	–	﹤0.01%	1265
2025 Q2	$58.9K	Buy	+4,360	New	+$58.9K	﹤0.01%	1183

CoreCap Advisors's ZIVO Position: Q2 2026 in Review

CoreCap Advisors held its Zivo Bioscience, Inc. Common Stock (ZIVO) position steady in Q2 2026 at 4,360 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1853.

CoreCap Advisors first reported a position in ZIVO in Q2 2025 and has held it in 5 quarters since. The position peaked at $58.9K in Q2 2025. 1 fund tracked by Wall St. Rank holds ZIVO as of Q2 2026.

CoreCap Advisors held 4,360 shares of Zivo Bioscience, Inc. Common Stock worth $17.6K as of Q2 2026.
CoreCap Advisors left its Zivo Bioscience, Inc. Common Stock share count unchanged in Q2 2026.
Zivo Bioscience, Inc. Common Stock made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1853 holding.
CoreCap Advisors first reported a position in Zivo Bioscience, Inc. Common Stock in Q2 2025 and has held it in 5 quarters since.
CoreCap Advisors's Zivo Bioscience, Inc. Common Stock position peaked at $58.9K in Q2 2025.
1 fund tracked by Wall St. Rank held Zivo Bioscience, Inc. Common Stock as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.